U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07747948) titled 'Population Pharmacokinetics of Apixaban in Asian Patients With Atrial Fibrillation' on May 11.
Brief Summary: The goal of this observational study is to learn about the variability of apixaban blood levels and identify the clinical factors that influence them in Asian patients with atrial fibrillation. The main questions it aims to answer are:
1. What are the specific pharmacokinetic parameters and their variabilities for apixaban in this patient population?
2. Which clinical factors, such as kidney function or body weight, are the primary predictors of how apixaban is cleared and distributed in the body?
Participants will be aske...